Inmed Pharmaceuticals Inc (NQ: INM )
0.3977
-0.0023
(-0.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Inmed Pharmaceuticals Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stethoscope-g33e91cd10_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/blur-g53451ca14_1920.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3462.jpeg?width=720)
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Cannabis Conference
November 23, 2021
Topics
Cannabis
Exposures
Cannabis
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/02_29.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_61.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_334.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_494.png)
24 Stocks Moving in Thursday's Pre-Market Session
November 18, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cbd-gad526e318_1920.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/14433.jpg?v=0)
InMed Pharmaceuticals (INM): Progress Across the Business
November 17, 2021
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cbd-oil-g7cd95ab7b_1920.jpg?width=720)
InMed Pharmaceuticals Files Patent Application for Treatment of Neurodegenerative Diseases with Rare Cannabinoid
November 11, 2021
InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabi...
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cbd-gba091171e_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cbd-ga27ec9e7d_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_315.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_42.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_475.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.